1,2-distearoylphosphatidylethanolamine has been researched along with tanespimycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandran, T; Katragadda, U; Tan, C; Teng, Q | 1 |
| Choi, HG; Gautam, M; Gupta, B; Jeong, JH; Kim, JO; Lee, JS; Pathak, S; Poudel, BK; Regmi, S; Ruttala, HB; Yong, CS | 1 |
2 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and tanespimycin
| Article | Year |
|---|---|
Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG).
Topics: Antineoplastic Agents; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Carriers; Drug Design; Drug Evaluation, Preclinical; Drug Stability; Drug Storage; Humans; Lactams, Macrocyclic; Magnetic Resonance Spectroscopy; Micelles; Nanoparticles; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Solubility; Vitamin E | 2010 |
Folate receptor-targeted hybrid lipid-core nanocapsules for sequential delivery of doxorubicin and tanespimycin.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Biomarkers; Dimethyl Sulfoxide; Doxorubicin; Drug Delivery Systems; Fatty Acids, Monounsaturated; Folate Receptor 1; Folic Acid; Gene Expression; Humans; Injections, Intravenous; Lactams, Macrocyclic; Male; MCF-7 Cells; Micelles; Nanocapsules; Neoplasm Proteins; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley | 2017 |